|
1
|
Spiro RH: Salivary neoplasms: Overview of
a 35-year experience with 2,807 patients. Head Neck Surg.
8:177–184. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Valstar MH, de Ridder M, van den Broek EC,
Stuiver MM, van Dijk BAC, van Velthuysen MLF, Balm AJM and Smeele
LE: Salivary gland pleomorphic adenoma in the Netherlands: A
nationwide observational study of primary tumor incidence,
malignant transformation, recurrence, and risk factors for
recurrence. Oral Oncol. 66:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bist SS, Luthra M, Agrawal V and Shirazi
N: Giant parapharyngeal space pleomorphic adenoma causing acute
airway obstruction. Oman Med J. 32:240–242. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Witt RL: The significance of the margin in
parotid surgery for pleomorphic adenoma. Laryngoscope.
112:2141–2154. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ghosh S, Panarese A, Bull PD and Lee JA:
Marginally excised parotid pleomorphic salivary adenomas: Risk
factors for recurrence and management. A 12.5-year mean follow-up
study of histologically marginal excisions. Clin Otolaryngol Allied
Sci. 28:262–266. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guntinas-Lichius O, Kick C, Klussmann JP,
Jungehuelsing M and Stennert E: Pleomorphic adenoma of the parotid
gland: A 13-year experience of consequent management by lateral or
total parotidectomy. Eur Arch Otorhinolaryngol. 261:143–146. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stennert E, Wittekindt C, Klussmann JP,
Arnold G and Guntinas-Lichius O: Recurrent pleomorphic adenoma of
the parotid gland: A prospective histopathological and
immunohistochemical study. Laryngoscope. 114:158–163. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park GC, Cho KJ, Kang J, Roh JL, Choi SH,
Kim SY and Nam SY: Relationship between histopathology of
pleomorphic adenoma in the parotid gland and recurrence after
superficial parotidectomy. J Surg Oncol. 106:942–946. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Glas AS, Hollema H, Nap RE and Plukker JT:
Expression of estrogen receptor, progesterone receptor, and
insulin-like growth factor receptor-1 and of MIB-1 in patients with
recurrent pleomorphic adenoma of the parotid gland. Cancer.
94:2211–2216. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hamada T, Matsukita S, Goto M, Kitajima S,
Batra SK, Irimura T, Sueyoshi K, Sugihara K and Yonezawa S: Mucin
expression in pleomorphic adenoma of salivary gland: A potential
role for MUC1 as a marker to predict recurrence. J Clin Pathol.
57:813–821. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Soares AB, de Araújo VC, Juliano PB and
Altemani A: Angiogenic and lymphangiogenic microvessel density in
recurrent pleomorphic adenoma. J Oral Pathol Med. 38:623–629. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsuyama A, Hisaoka M, Nagao Y and
Hashimoto H: Aberrant PLAG1 expression in pleomorphic adenomas of
the salivary gland: A molecular genetic and immunohistochemical
study. Virchows Arch. 458:583–592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Brito BS, Gaspar NG, Egal ES,
Sanchez-Romero C, Martins AS, Tincani ÁJ, de Oliveira Gondak R, de
Almeida OP, Kowalski LP, Altemani A and Mariano FV: PLAG1
expression is maintained in recurrent pleomorphic adenoma. Virchows
Arch. 469:477–481. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mark J, Dahlenfors R and Ekedahl C:
Cytogenetics of the human benign mixed salivary gland tumour.
Hereditas. 99:115–129. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mark J, Dahlenfors R and Wedell B: Impact
of the in vitro technique used on the cytogenetic patterns in
pleomorphic adenomas. Cancer Genet Cytogenet. 95:9–15. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Craver RD, Fonseca P and Carr R: Pediatric
epithelial salivary gland tumors: Spectrum of histologies and
cytogenetics at a children's hospital. Pediatr Dev Pathol.
13:348–353. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ochal-Choińska AJ and Osuch-Wójcikiewicz
E: Particular aspects in the cytogenetics and molecular biology of
salivary gland tumours-current review of reports. Contemp Oncol
(Pozn). 20:281–286. 2016.PubMed/NCBI
|
|
18
|
Nibert M and Heim S: Uterine leiomyoma
cytogenetics. Genes Chromosomes Cancer. 2:3–13. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Manor E, Joshua BZ, Brennan PA and Bodner
L: Chromosomal aberrations in minor salivary gland pleomorphic
adenoma. J Oral Maxillofac Surg. 70:2798–2801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alyahya GA, Stenman G, Persson F, Prause
JU, Skjødt K, Saunte JP and Heegaard S: Pleomorphic adenoma arising
in an accessory lacrimal gland of Wolfring. Ophthalmology.
113:879–882. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kandasamy J, Smith A, Diaz S, Rose B and
O'Brien C: Heterogeneity of PLAG1 gene rearrangements in
pleomorphic adenoma. Cancer Genet Cytogenet. 177:1–5. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sato K, Ueda Y, Shimasaki M, Ozaki M,
Nitta N, Chada K, Ishikawa Y and Katsuda S: Pleomorphic adenoma
(benign mixed tumor) of the breast: A case report and review of the
literature. Pathol Res Pract. 201:333–339. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McGowan-Jordan J, Simons A and Schmid M:
ISCN 2016: An International System for Human Cytogenomic
Nomenclature. Karger; Basel: pp. 1492016
|
|
24
|
Weise A and Liehr T: Pre- and postnatal
diagnostics and research on peripheral blood, bone marrow chorion,
amniocytes, and fibroblasts. Fluorescence In Situ Hybridization
(FISH)-Application Guide. 2nd. Liehr T: Springer; Berlin: pp.
171–180. 2017, View Article : Google Scholar
|
|
25
|
Claussen U, Michel S, Mühlig P, Westermann
M, Grummt UW, Kromeyer-Hauschild K and Liehr T: Demystifying
chromosome preparation and the implications for the concept of
chromosome condensation during mitosis. Cytogenet Genome Res.
98:136–146. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liehr T and Claussen U: Current
developments in human molecular cytogenetic techniques. Curr Mol
Med. 2:283–297. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weise A and Liehr T: Background.
Fluorescence In Situ Hybridization (FISH)-Application Guide. 2nd.
Liehr T: Springer; Berlin: pp. 1–14. 2017
|
|
28
|
Othman MA, Melo JB, Carreira IM, Rincic M,
Glaser A, Grygalewicz B, Gruhn B, Wilhelm K, Rittscher K, Meyer B,
et al: High rates of submicroscopic aberrations in karyotypically
normal acute lymphoblastic leukemia. Mol Cytogenet. 8:452015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liehr T, Othman MA and Rittscher K:
Multicolor karyotyping and fluorescence in situ
hybridization-banding (MCB/mBAND). Methods Mol Biol. 1541:181–187.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miller CR, Stephens D, Ruppert AS, Racke
F, McFaddin A, Breidenbach H, Lin HJ, Waller K, Bannerman T, Jones
JA, et al: Jumping translocations, a novel finding in chronic
lymphocytic leukaemia. Br J Haematol. 170:200–207. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hoffmann F, Umbreit C, Krüger T, Pelzel D,
Ernst G, Kniemeyer O, Guntinas-Lichius O, Berndt A and von Eggeling
F: Identification of proteomic markers in head and neck cancer
using MALDI-MS imaging, LC-MS/MS, and immunohistochemistry.
Proteomics Clin Appl. 13:e17001732019. View Article : Google Scholar : PubMed/NCBI
|
